CN205885876U - Hyperlipidemia treatment filter - Google Patents

Hyperlipidemia treatment filter Download PDF

Info

Publication number
CN205885876U
CN205885876U CN201620625262.1U CN201620625262U CN205885876U CN 205885876 U CN205885876 U CN 205885876U CN 201620625262 U CN201620625262 U CN 201620625262U CN 205885876 U CN205885876 U CN 205885876U
Authority
CN
China
Prior art keywords
carbon film
thickness
filter
blood
layer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN201620625262.1U
Other languages
Chinese (zh)
Inventor
蒋农发
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Yixing Bernard Investment Co Ltd
Original Assignee
Jiangsu Bofa Biotechnology Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jiangsu Bofa Biotechnology Co Ltd filed Critical Jiangsu Bofa Biotechnology Co Ltd
Priority to CN201620625262.1U priority Critical patent/CN205885876U/en
Application granted granted Critical
Publication of CN205885876U publication Critical patent/CN205885876U/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • External Artificial Organs (AREA)

Abstract

The utility model relates to a hyperlipidemia treatment filter, it includes the casing the casing top is equipped with blood inlet and gas vent respectively the casing bottom is equipped with blood and exports be equipped with the filter layer in the casing, does the filter layer include down from last that six layers of aperture are 0.5 0.6 mu m's carbon film and the poly(ether sulfone) filtration membrane that the one deck aperture is 0.2 mu m, the thickness of six layers of carbon film is the same, and the thickness of every layer of carbon film is 5mm, and is individual layer carbon film and poly(ether sulfone) filtration membrane's thickness than being (8 10 ): 1. The utility model discloses a low cholesterol, triglyceride and low density lipoprotein effectively fall in the blood extracorporal circulatory system.

Description

Hyperlipemia therapeutic filter
Technical field
This utility model is related to a kind of medical apparatus and instruments and in particular to a kind of hyperlipemia defecator.
Background technology
In recent years, the crowd of hyperlipemia has the trend of increase, and Hyperlipemia is a dangerous signal, because it can Lead to coronary heart disease, cerebral infarction and atheroangitis disease, its arch-criminal is low density lipoprotein, LDL in blood.At present, reduce The main method of human body lipids contents is come reduction blood fat using medicine, but drug effect inconspicuous, medicine also can be to human body simultaneously Bring side effect.
Content of the invention
Goal of the invention: the purpose of this utility model is to overcome deficiency of the prior art, providing a kind of patient to pass through Blood extracorporeal circulation, effectively reduces the hyperlipemia therapeutic filter of cholesterol, triglyceride and low density lipoprotein, LDL.
Technical scheme: in order to solve above-mentioned technical problem, hyperlipemia therapeutic filter described in the utility model, it wraps Include housing, be respectively equipped with blood entry port and air vent in described case top, be provided with blood outlet in described housing bottom, in institute State and in housing, be provided with filter layer, described filter layer includes the carbon film for 0.5-0.6 μm for the six layers of aperture and one layer of aperture from top to bottom Polyethersulfone filter film for 0.2 μm, the thickness of six layers of carbon film is identical, and the thickness of every layer of carbon film is 5mm, monolayer carbon film and polyether sulfone The thickness ratio of filter membrane is (8-10): 1.
The thickness of described polyethersulfone filter film is 0.5 mm.
A diameter of 150 mm of described housing.
Described housing is divided into lid and lower cover, and they are integral type structure.
Beneficial effect: compared with prior art, its remarkable advantage is this utility model: this utility model overall structure letter Single, using integral structure, easy to process, high in machining efficiency, it is (8-10) using thickness ratio: 1 aperture is 0.5-0.6 μm of carbon Film and the polyethersulfone filter film that aperture is 0.2 μm, and carbon film arranges six layers, and patient passes through blood extracorporeal circulation, effectively reduces Other harmful substances matter in cholesterol, triglyceride, low density lipoprotein, LDL and blood, thus effectively treatment hyperlipemia, meets Actual operation requirements.
Brief description
Fig. 1 is structural representation of the present utility model.
Specific embodiment
With reference to the accompanying drawings and examples this utility model is further described.
As shown in figure 1, hyperlipemia therapeutic filter described in the utility model, it includes housing 1, in described housing 1 Top is respectively equipped with blood entry port 2 and air vent 3, is provided with blood outlet 4 in described housing 1 bottom, is provided with described housing 1 Filter layer, described filter layer includes carbon film 5 that six layers of aperture are 0.5-0.6 μm from top to bottom and one layer of aperture is 0.2 μm poly- Ether sulfone filter membrane 6, the thickness of six layers of carbon film 5 is identical, and the thickness of every layer of carbon film 5 is 5mm, monolayer carbon film 5 and polyethersulfone filter film 6 Thickness than be (8-10): 1;The thickness of described polyethersulfone filter film 6 is 0.5 mm;A diameter of 150 mm of described housing 1;Institute State housing 1 and be divided into lid 7 and lower cover 8, they are integral type structure.This utility model overall structure is simple, using integral type knot Structure, easy to process, high in machining efficiency, using thickness than being (8-10): 1 aperture is 0.5-0.6 μm of carbon film and aperture is 0.2 μm Polyethersulfone filter film, and carbon film arrange six layers, patient pass through blood extracorporeal circulation, effectively reduce cholesterol, triglyceride, Other harmful substances matter in low density lipoprotein, LDL and blood, thus effectively treatment hyperlipemia, meets actual operation requirements.
This utility model provides a kind of thinking and method, and the method and the approach that implement this technical scheme are a lot, with It is only preferred implementation of the present utility model described in upper it is noted that for those skilled in the art, On the premise of without departing from this utility model principle, some improvements and modifications can also be made, these improvements and modifications also should regard For protection domain of the present utility model, in the present embodiment, all available prior art of clearly not each ingredient is realized.

Claims (4)

1. hyperlipemia therapeutic filter it is characterised in that: it includes housing (1), is respectively equipped with blood at described housing (1) top Liquid entrance (2) and air vent (3), are provided with blood outlet (4) in described housing (1) bottom, are provided with filtration in described housing (1) Layer, described filter layer includes the carbon film (5) that six layers of aperture are 0.5-0.6 μm and the polyethers that one layer of aperture is 0.2 μm from top to bottom Sulfone filter membrane (6), the thickness of six layers of carbon film (5) is identical, and the thickness of every layer of carbon film (5) is 5mm, monolayer carbon film (5) and polyether sulfone The thickness ratio of filter membrane (6) is (8-10): 1.
2. hyperlipemia therapeutic filter according to claim 1 it is characterised in that: described polyethersulfone filter film (6) Thickness is 0.5 mm.
3. hyperlipemia therapeutic filter according to claim 1 it is characterised in that: a diameter of the 150 of described housing (1) mm.
4. hyperlipemia therapeutic filter according to claim 1 it is characterised in that: described housing (1) is divided into lid (7) With lower cover (8), they are integral type structure.
CN201620625262.1U 2016-06-23 2016-06-23 Hyperlipidemia treatment filter Expired - Fee Related CN205885876U (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201620625262.1U CN205885876U (en) 2016-06-23 2016-06-23 Hyperlipidemia treatment filter

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201620625262.1U CN205885876U (en) 2016-06-23 2016-06-23 Hyperlipidemia treatment filter

Publications (1)

Publication Number Publication Date
CN205885876U true CN205885876U (en) 2017-01-18

Family

ID=57768748

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201620625262.1U Expired - Fee Related CN205885876U (en) 2016-06-23 2016-06-23 Hyperlipidemia treatment filter

Country Status (1)

Country Link
CN (1) CN205885876U (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107537076A (en) * 2016-06-23 2018-01-05 江苏博发生物科技有限公司 Hyperlipemia therapeutic filter

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107537076A (en) * 2016-06-23 2018-01-05 江苏博发生物科技有限公司 Hyperlipemia therapeutic filter

Similar Documents

Publication Publication Date Title
CN203507201U (en) Separating type hemodialysis absorber
CN104800902A (en) Extracorporeal circulation life supporting device for treating and curing multiple organ failure
IT9067168A1 (en) BLOOD PURIFICATION EQUIPMENT, PARTICULARLY FOR THE TREATMENT OF PATIENTS WITH RENAL INSUFFICIENCY, AND PROCEDURE FOR THE PRODUCTION OF REINFUSION LIQUID FOR HEMODIAFILTRATION (HDF)
CN208943042U (en) For treating the plasma filtering device of hyperlipidemia
CN205073378U (en) Get rid of bilirubin blood purifying filter
CN103933163B (en) A kind of Chinese material bathe agent for the treatment of skin pruritus after hemodialysis
CN104117104A (en) Integrated blood purification device with blood perfusion structure and blood dialysis structure
CN205885876U (en) Hyperlipidemia treatment filter
CN104815360A (en) Circulating tumor cell filtration treatment instrument
CN205885875U (en) Eye ground artery blocks treatment filter
CN206027207U (en) Coronary heart disease treatment filter
CN103157154A (en) Filter and infusion apparatus used for infusion apparatus fine filtration
CN202289023U (en) Precision filtering transfusion set
CN203989273U (en) A kind of automatic vent accurate filter
CN203989183U (en) The apparatus for purifying blood of integrated strip hemoperfusion and hemodialysis structure
CN205796973U (en) Hepatitis b virus filter
CN200994952Y (en) Blood filter
CN203075351U (en) Filter for secondary filtering of infusion apparatus and infusion apparatus
CN206275864U (en) A kind of novel hemodialysis device
CN203507204U (en) Integrated hemodialysis absorber
CN207520398U (en) Anti-freezing negative pressure blood screening pipe in synchronous blood collection procedure
CN107537076A (en) Hyperlipemia therapeutic filter
CN216022409U (en) Neuroimmune disease treatment system
CN107537075A (en) Eyeground arterial obstruction treats filter
TWM514856U (en) Peripheral blood collection kit

Legal Events

Date Code Title Description
C14 Grant of patent or utility model
GR01 Patent grant
TR01 Transfer of patent right

Effective date of registration: 20171211

Address after: 214200 Huaxing Road, Yicheng street, Yixing City, Wuxi, Jiangsu Province, No. 108

Patentee after: Hang Yuxian

Address before: 214200 Huaxing Road, Yicheng street, Yixing City, Wuxi, Jiangsu Province, No. 108

Patentee before: JIANGSU BOFA BIOTECHNOLOGY CO., LTD.

TR01 Transfer of patent right
TR01 Transfer of patent right

Effective date of registration: 20180814

Address after: 214213 101, room 2, Yixing Photoelectric Industrial Park, 10 Xing Li Road, Yixing economic and Technological Development Zone, Yixing, Jiangsu

Patentee after: Yixing Bernard Investment Co., Ltd.

Address before: 214200 No. 108 Huaxing Road, Yicheng street, Yixing, Wuxi, Jiangsu

Patentee before: Hang Yuxian

TR01 Transfer of patent right
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20170118

Termination date: 20210623

CF01 Termination of patent right due to non-payment of annual fee